C
Market Data
$1.68−$0.20 (−10.64%)
CMMB · Last trade
Prev Close
$1.88
Range (29d)
$1.46 – $2.14
Recent Filings
- 6-K1.0 MBChemomab Therapeutics Ltd.Mar 20, 4:05 PM ET·0001178913-26-001571
- 6-K362.0 KBChemomab Therapeutics Ltd.Mar 19, 8:05 AM ET·0001178913-26-001550
- 6-K214.2 KBChemomab Therapeutics Ltd.Nov 21, 6:15 AM ET·0001178913-25-003932
- 6-K11.2 KBChemomab Therapeutics Ltd.Aug 22, 4:05 PM ET·0001178913-25-003015
- 6-K3.3 MBChemomab Therapeutics Ltd.Aug 14, 8:01 AM ET·0001178913-25-002894
- 6-K931.4 KBChemomab Therapeutics Ltd.Jul 25, 4:33 PM ET·0001178913-25-002465
- 6-K10.6 KBChemomab Therapeutics Ltd.Jul 1, 4:05 PM ET·0001178913-25-002278
- 6-K1.5 MBChemomab Therapeutics Ltd.May 27, 4:05 PM ET·0001178913-25-001967
- 6-K232.3 KBChemomab Therapeutics Ltd.May 15, 8:00 AM ET·0001178913-25-001807
- 6-K70.0 KBChemomab Therapeutics Ltd.Apr 15, 8:00 AM ET·0001178913-25-001306
Insiders
10- Access Industries Holdings LLC10% Owner
- ACCESS INDUSTRIES, LLCAffiliate of 10% Owner
- ACCESS INDUSTRIES MANAGEMENT, LLCAffiliate of 10% Owner
- Aharon ArnonChief Medical Officer
- Alon RuthDirector
- Blavatnik LenAffiliate of 10% Owner
- Burgin JonathanSee Remarks
- Cohen Neil HarrisDirector, interim CEO
- Daly Sean TVP, Clinical Operations
- Darvish NissimDirector
Tickers
Addresses
business
KIRYAT ATIDIM, BUILDING 7
TEL AVIV
mailing
KIRYAT ATIDIM, BUILDING 7
TEL AVIV
Former Names
- Anchiano Therapeutics Ltd.2021-03-17
- BioCancell Ltd.2015-11-03